Endo Pharmaceuticals Inc. v. West-Ward Pharmaceuticals International Limited
1:14-cv-01387
Overview
Parties
Defendant
Hikma Pharmaceuticals USA Inc. Operating Company
Represented By
1 Attorneys ListedMurphy, Spadaro & Landon
Murphy, Spadaro & Landon, 1011 Centre Road
West-Ward Pharmaceuticals International Limited NPE (University / Research)
Represented By
5 Attorneys ListedMurphy, Spadaro & Landon
Murphy, Spadaro & Landon, 1011 Centre Road
Plaintiff
Mallinckrodt LLC Operating Company
Represented By
3 Attorneys ListedPolsinelli PC
222 Delaware Avenue, Suite 1101, Wilmington, DE 19801
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Endo Pharmaceuticals Inc. Operating Company
Represented By
7 Attorneys ListedPolsinelli PC
222 Delaware Avenue, Suite 1101, Wilmington, DE 19801
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8808737
Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment
|
Filed: 2010-03-03
Issued: 2014-08-19
|
Active (3.3 yrs remaining)
Expires: 2030-03-03
|
|
|
US8871779
Process for preparing morphinan-6-one products with low levels of α,β-unsaturated ketone compounds
|
Filed: 2007-03-02
Issued: 2014-10-28
|
Active (3.0 yrs remaining)
+996d PTA
Expires: 2029-11-22
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
29
Dispositive
9
Granted
0
Denied
0
Pending / Review
24
Motions by Category
Key Dispositive Motions & Rulings